ArticleCancers2024

Adverse Events in Anti-PD-1-Treated Adjuvant and First-Line Advanced Melanoma Patients.

Daan Jan Willem Rauwerdink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.